News brief
According to Presspool, AI drug R&D company Opsin completed USD 21 million in financing, with participation from SYN Ventures and Race Capital.
Connected profiles
Explore
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- presspool.ai ↗Published Oct 15, 2026
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
据Presspool报道，AI药物研发公司Opsin完成2100万美元融资，由SYN Ventures与Race Capital参投。